Physician profile
David Jerome Applebaum
NPI 1497819338
$43,874.57
in general payments reported to CMS, 2019-2025
7 companies · $4,587 in 2025
The $4,587 reported for 2025 was more than what 92% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $3,266 · 2021: $7,216 · 2022: $181 · 2023: $9,129 · 2024: $5,196 · 2025: $4,587.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $18K · Food and Beverage: $907 · Education: $5.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,000.00 |
| Food and Beverage | $907.10 |
| Education | $5.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $42,714.62 | 2019-2025 | Dysport |
| Mentor Worldwide LLC | $388.28 | 2020-2024 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Abbvie INC. | $207.88 | 2023-2025 | |
| Allergan, INC. | $205.03 | 2019-2022 | |
| Revance Therapeutics, INC. | $161.29 | 2024 | Daxxify |
| Solta Medical, A Division of Bausch Health US, LLC | $149.48 | 2024 | |
| Eagle Pharmaceuticals, INC. | $47.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Applebaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.